Abstract
Sydenham’s chorea is a post-streptoccocal movement disorder and one of the major criteria for the diagnosis of rheumatic fever. The likely pathophysiological mechanism involves induction, as a response to the infection, of antibodies that cross-react with the basal ganglia. Anti-basal ganglia antibodies are found in 45–100% of patients with Sydenham’s chorea, and their levels correlate with disease activity.
Further post-streptococcal non-rheumatic neurologic disorders include the contested condition PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) and other diseases such as disseminated encephalomyelitis with basal ganglia lesions; acute myoclonus; isolated striatal necrosis; paroxysmal dystonic choreoathetosis; acute parkinsonism; and the opsoclonus-myoclonus syndrome. In many of these conditions, antineuronal antibodies are detected raising the hypothesis of a common autoimmune pathophysiological mechanism.
The symptoms of Sydenham’s chorea, PANDAS, and other post-streptococcal CNS disorders can evolve rapidly, often requiring prompt intervention. Management of post-streptococcal CNS disorders includes symptomatic treatment of the acute movement disorder and/or psychiatric problem; antibiotic therapy; and immunotherapy.
This chapter contains video segments that can be found on the accompanying DVD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jummani R, Okun M. Sydenham chorea. Neurology. 2001;58:311–3.
Shiffman RN. Guideline maintenance and revision; 50 years of the Jones criteria for diagnosis of rheumatic fever. Arch Pediatr Adolesc Med. 1995;149:727–32.
Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. Am J Psychiatry. 1989;146:246–9.
Swedo SE. Sydenham’s chorea; a model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788–91.
Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264–71.
Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol. 2001;50:588–95.
DiFazio MP, Morales J, Davis R. Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: a PANDAS variant. J Child Neurol. 1998;13:516–8.
Dale RC, Church AJ, Benton S, et al. Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis. Dev Med Child Neurol. 2002;44:485–9.
Dale RC, Church AJ, Surtees RA, Thompson EJ, Giovannoni G, Neville BGR. Post-streptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis. Mov Disord. 2002;17:817–20.
McKee DH, Sussman JD. Case report: severe acute parkinsonism associated with streptococcal infection and antibasal ganglia antibodies. Mov Disord. 2005;20:1661–3.
Candler PM, Dale RC, Griffin S, et al. Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies. J Neurol Neurosurg Psychiatry. 2006;77:507–12.
Dale RC. Autoimmunity and the basal ganglia: new insights into old diseases. QJM. 2003;96:183–91.
Cardoso F, Eduardo C, Silva AP, Mota CC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12:701–3.
Carapetis JR, Currie BJ. Rheumatic fever in a high incidence population: the importance of monoarthritis and low-grade fever. Arch Dis Child. 2001;85:223–7.
Terreri MT, Roja SC, Len CA, Faustino PC, Roberto AM, Hilario MO. Sydenham’s chorea—clinical and evolutive characteristics. Sao Paulo Med J. 2002;120:16–9.
Ghram N, Allani C, Oudali B, Fitouri Z, Ben Becher S. Sydenham’s chorea in children. Arch Pediatr. 1999;6:1048–52.
Nausieda PA, Grossman BJ, Koller WC, Weiner WJ, Klawans HL. Sydenham chorea: an update. Neurology. 1980;30:331–4.
Al-Eissa A. Sydenham’s chorea: a new look at an old disease. Br J Clin Pract. 1993;47:14–6.
Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham’s chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002;24:73–6.
Asbahr FR, Negrao AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998;155:1122–4.
Mercadante MT, Busatto GF, Lombroso PJ, et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000;157:2036–8.
Cardoso F, Vargas AP, Oliveira LD, Guerra AA, Amaral SV. Persistent Sydenham’s chorea. Mov Disord. 1999;14:805–7.
Giedd JN, Rapoport JL, Kruesi MJ, et al. Sydenham’s chorea: magnetic resonance imaging of the basal ganglia. Neurology. 1995;45:2199–202.
Castillo M, Kwock L, Arbelaez A. Sydenham’s chorea: MRI and proton spectroscopy. Neuroradiology. 1999;41:943–5.
Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123:2407–22.
Leuzzi V, Bertini E, De Negri AM, Gallucci M, Garavaglia B. Bilateral striatal necrosis, dystonia and optic atrophy in two siblings. J Neurol Neurosurg Psychiatry. 1992;55:16–9.
Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry. 2000;157:281–3.
Barsottini OGP, Ferraz HB, Seviliano MM, Barbieri A. Brain SPECT imaging in Sydenham’s chorea. Braz J Med Biol Res. 2002;35:431–6.
Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams Jr RC. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976;144:1094–110.
Kotby AA, El Badawy N, El Sokkary S, Moawad H, El Shawarby M. Antineuronal antibodies in rheumatic chorea. Clin Diagn Lab Immunol 1998;5:836–839
Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002;59:227–31.
Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry. 2003;74:602–7.
Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenham’s chorea. J Immunol. 2007;178:7412–21.
Swedo SE. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry. 2002;7:S24–5.
Khanna AK, Buskirk DR, Williams Jr RC, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 1989;83:1710–6.
Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110–2.
Kurlan R. Tourette’s syndrome and ‘PANDAS’: will the relation bear out? Neurology. 1998;50:1530–4.
Daoud AS, Zaki M, Shakir R, Al-Saleh Q. Effectiveness of sodium valproate in the treatment of Sydenham’s chorea. Neurology. 1990;40:1140–1.
Pena J, Mora E, Cardozo J, Molina O, Montiel C. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham’s chorea: clinical follow-up of 18 patients. Arq Neuropsiquiatr. 2002;60:374–7.
Roig M, Montserrat L, Gallart A. Carbamazepine: an alternative drug for the treatment of nonhereditary chorea. Pediatrics. 1988;82:492–5.
Harel L, Zecharia A, Straussberg R, Volovitz B, Amir J. Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol. 2000;23:147–51.
Harries-Jones R, Gibson JG. Successful treatment of refractory Sydenham’s chorea with pimozide. J Neurol Neurosurg Psychiatry. 1985;48:390.
Shannon KM, Fenichel GM. Pimozide treatment of Sydenham’s chorea. Neurology. 1990;40:186.
Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis. 2001;33:806–14.
Green LN. Corticosteroids in the treatment of Sydenham’s chorea. Arch Neurol. 1978;35: 53–4.
Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20:424–9.
Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156:356–61.
Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354:1153–8.
Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry. 1999;45: 1564–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
Movement_Disorders_Emergencies_C13.mov (25,945 KB)
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pons, R. (2013). Sydenham’s Chorea, PANDAS, and Other Post-streptococcal Neurological Disorders. In: Frucht, S. (eds) Movement Disorder Emergencies. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-835-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-60761-835-5_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-834-8
Online ISBN: 978-1-60761-835-5
eBook Packages: MedicineMedicine (R0)